Product Center
Obtained Recognition as One of the First Offshore Innovation Centers for Enterprises in Taizhou
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-08-14
- Views:
(Summary description)Recently, the Science and Technology Bureau of Taizhou City announced the first batch of offshore innovation centers for enterprises, and Ab&B Bio-Tech Co., Ltd. (Ab&B Bio) wholly-owned subsidiary Yither Biotech (Shanghai) Co., Ltd. (Yither Bio) successfully obtained recognition.
Obtained Recognition as One of the First Offshore Innovation Centers for Enterprises in Taizhou
(Summary description)Recently, the Science and Technology Bureau of Taizhou City announced the first batch of offshore innovation centers for enterprises, and Ab&B Bio-Tech Co., Ltd. (Ab&B Bio) wholly-owned subsidiary Yither Biotech (Shanghai) Co., Ltd. (Yither Bio) successfully obtained recognition.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-08-14 18:02
- Views:
Recently, the Science and Technology Bureau of Taizhou City announced the first batch of offshore innovation centers for enterprises, and Ab&B Bio-Tech Co., Ltd. (Ab&B Bio) wholly-owned subsidiary Yither Biotech (Shanghai) Co., Ltd. (Yither Bio) successfully obtained recognition.
Since its establishment, Yither Bio has jointly established a collaborative innovation model of "offshore research and development incubation, local transformation and application" with Ab&B Bio, leveraging advanced regional innovative resources to carry out key core technology research and development. As of now, two clinical approvals for Class I new drugs have been successfully jointly applied for and approved.
Next, the company will also actively promote the two-way linkage between local innovation and offshore innovation, strengthen the exchange, interaction and circulation of talents, cultivate a batch of scientific and technological innovation achievements, and continue to complete the implementation and application of innovation achievements, so as to help the high-quality development of the city's biomedical industry!
Relevant information
-
The Launch Meeting of Phase I/II Clinical Trial for Recombinant Herpes Zoster Vaccine (CHO Cell) was successfully heldRecently, the Phase I/II clinical trial launch meeting for the recombinant herpes zoster vaccine (CHO cell), co-developed by Ab&B Bio-Tech CO., LTD. JS. and Yither Biotech (Shanghai) Co., Ltd., was successfully held in Henan, and the first-in-human (FIH) dosing was successfully completed. - Ab&B Bio and Yither Bio Have Both Obtained Qualification Certification! 12-30
- Kickoff Meeting for Clinical Research on Quadrivalent Influenza Virus Subunit Vaccine in Children with Nephrotic Syndrome Successfully Held 12-25
- IND Application for Influenza Virus Subunit Vaccine (Adjuvanted) Approved 10-30
- The Application for the Marketing of Trivalent Influenza Virus Subunit Vaccine has been Accepted! 10-08
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
